International Journal of Advanced Community Medicine
International Journal of Advanced Community Medicine
Vol. 2, Issue 3, Part B (2019)

Dramatic response of Mirena (levonorgestrel intrauterine system) in treatment of menorrhagia

Author(s): Dr. Athmar Ali Mousa Fridawi, Dr. Rafida Nasif Jasim and Dr. Maha Ismaeel Khudhuer
Abstract: Background: Menorrhagia is a type of menstrual disorder that is characterized by the presence of red vaginal discharge from the uterine cavity on a regular basis, but excessive in quantity (greater than 80 ml) and / or duration (greater than 7 days).
Objective: To study the dramatic response of levonorgestrel intrauterine system (LNG-IUS) Mirena for treatment of menorrhagia during its use as contraceptive.
Matera and methods: 30 women between 30 and 50 year with menorrhagia were included in a study over two year. Response was assessed monthly for first 4 month and then yearly for maximum 2 year.
Result; Mirena caused decrease in blood loss (MBL) in 16.7% of the patients at 4 month, 73.3% decrease in(MBL) by one year and 100% decrease by 2 years, and improved the mean Hb level in 100% of the patients after 2 years. Mirena has an effective in treatment of abnormal uterine bleeding and this made surgical intervention (Hysterectomy) is last choice.
Conclusion: LNG locally released on endometrium cavity is both a safe and reliable method of abnormal uterine bleeding treatment.
Pages: 85-89  |  724 Views  135 Downloads
How to cite this article:
Dr. Athmar Ali Mousa Fridawi, Dr. Rafida Nasif Jasim and Dr. Maha Ismaeel Khudhuer. Dramatic response of Mirena (levonorgestrel intrauterine system) in treatment of menorrhagia. International Journal of Advanced Community Medicine. 2019; 2(3): 85-89. DOI: 10.33545/comed.2019.v2.i3b.85
International Journal of Advanced Community Medicine